Biomarker-based treatment selection in early-stage rectal cancer to promote organ preservation.
about
Hypermethylated DNA, a circulating biomarker for colorectal cancer detectionEarly rectal cancer: the European Association for Endoscopic Surgery (EAES) clinical consensus conference.Germ line polymorphisms as predictive markers for pre-surgical radiochemotherapy in locally advanced rectal cancer: a 5-year literature update and critical review.Transanal endoscopic surgery: past, present and future.Colonic Laterally Spreading Tumor Diagnosed as an Early Cancer and Treated with Endoscopic Mucosal Resection: A Case Report and Review of Literature.Potentiating the effects of radiotherapy in rectal cancer: the role of aspirin, statins and metformin as adjuncts to therapy.
P2860
Biomarker-based treatment selection in early-stage rectal cancer to promote organ preservation.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Biomarker-based treatment sele ...... to promote organ preservation.
@ast
Biomarker-based treatment sele ...... to promote organ preservation.
@en
Biomarker-based treatment sele ...... to promote organ preservation.
@nl
type
label
Biomarker-based treatment sele ...... to promote organ preservation.
@ast
Biomarker-based treatment sele ...... to promote organ preservation.
@en
Biomarker-based treatment sele ...... to promote organ preservation.
@nl
prefLabel
Biomarker-based treatment sele ...... to promote organ preservation.
@ast
Biomarker-based treatment sele ...... to promote organ preservation.
@en
Biomarker-based treatment sele ...... to promote organ preservation.
@nl
P2093
P2860
P356
P1476
Biomarker-based treatment sele ...... to promote organ preservation
@en
P2093
P2860
P304
P356
10.1002/BJS.9571
P407
P577
2014-07-23T00:00:00Z